Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of Hibbett, Inc. (NASDAQ:HIBB) rose sharply in today's pre-market trading after the company agreed to be acquired by JD Sports Fashion for $87.50 per share in cash, in a $1.1 billion transaction.

Hibbett shares jumped 18.4% to $85.83 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Pineapple Energy Inc. (NASDAQ:PEGY) shares gained 38% to $0.0632 in pre-market trading after falling 10% on Monday
• ImmunityBio, Inc. (NASDAQ:IBRX) gained 34.6% to $6.65 in pre-market trading after the company received FDA approval for ANKTIVA, a first-in-class IL-15 receptor agonist, for BCG-unresponsive non-muscle invasive bladder cancer.
• Nuwellis, Inc. (NASDAQ:NUWE) gained 31.5% to $0.43 in pre-market trading after the company received a notice of allowance for its U.S. patent application 18/463,612 titled “Venous Blood Flow Stimulator For Extracorporeal Therapy”
• AGBA Group Holding Limited (NASDAQ:AGBA) climbed 24% to $3.10 in pre-market trading on continued upward momentum after the company on Friday announced it entered into a definitive merger agreement with Triller.
• HWH International Inc. (NASDAQ:HWH) rose 15.5% to $1.48 in today's pre-market trading after declining 3% on Monday.
• Theriva Biologics, Inc. (NYSE:TOVX) gained 15.5% to $0.4748 in pre-market trading after the company announced it will present preclinical data for the potential synergy of VCN-01 and first-line pancreatic cancer chemotherapy regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting.
• Azitra, Inc. (NYSE:AZTR) shares gained 13.5% to $0.2216 in pre-market trading after the company announced new preclinical data will be presented at the American Society of Gene and Cell Therapy meeting.
• China Natural Resources, Inc. (NASDAQ:CHNR) shares gained 12% to $1.12 in pre-market trading.
• Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares rose 11.9% to $0.5750 in pre-market trading following upbeat quarterly results.

Losers

• Abeona Therapeutics Inc. (NASDAQ:ABEO) fell 48.1% to $3.82 in pre-market trading after the company announced the FDA issued a Complete Response Letter in response to the company’s Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
• Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) fell 31.1% to $0.0870 in pre-market trading after gaining over 8% on Monday.
• T2 Biosystems, Inc. (NASDAQ:TTOO) declined 18.7% to $2.57 in pre-market trading after gaining around 7% on Monday.
• Phio Pharmaceuticals Corp. (NASDAQ:PHIO) fell 16.8% to $0.69 in pre-market trading. Phio Pharmaceuticals shares jumped around 33% on Monday after the company announced that its intratumoral injection of murine PH-762 inhibited tumor growth in murine tumor models and may generate memory-specific T cells.
• Calix, Inc. (NYSE:CALX) shares fell 16.8% to $24.60 in pre-market trading after the company reported mixed first-quarter financial results and issued second-quarter guidance below estimates.
• Complete Solaria, Inc. (NASDAQ:CSLR) fell 13.7% to $0.3360 in pre-market trading after dipping around 14% on Monday.
• Tungray Technologies Inc. (NASDAQ:TRSG) shares declined 13.7% to $6.37 in pre-market trading after gaining 24% on Monday.
• Jaguar Health, Inc. (NASDAQ:JAGX) shares fell 12.1% to $0.1581 in pre-market trading after the company filed for a mixed shelf offering of up to $75 million.
• YY Group Holding Limited (NASDAQ:YYGH) fell 13.8% to $2.50 pre-market trading after tumbling over 27% on Monday. The company, last week, priced its IPO at $4 per share.
• Cadence Design Systems, Inc. (NASDAQ:CDNS) fell 5.7% to $268.91 pre-market trading after the company issued second-quarter guidance below estimates.

Now Read This: General Motors, Tesla And 3 Stocks To Watch Heading Into Tuesday